These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29189310)

  • 1. Muscle Damage Due to Fusidic Acid-Statin Interaction: Review of 75 Cases From the French Pharmacovigilance Database and Literature Reports.
    Bataillard M; Beyens MN; Mounier G; Vergnon-Miszczycha D; Bagheri H; Cathebras P
    Am J Ther; 2019; 26(3):e375-e379. PubMed ID: 29189310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid].
    Gabignon C; Zeller V; Le Guyader N; Desplaces N; Lidove O; Ziza JM
    Rev Med Interne; 2013 Jan; 34(1):39-41. PubMed ID: 23102978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyolysis after co-administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactions.
    Deljehier T; Pariente A; Miremont-Salamé G; Haramburu F; Nguyen L; Rubin S; Rigothier C; Théophile H
    Br J Clin Pharmacol; 2018 May; 84(5):1057-1063. PubMed ID: 29337401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presumed interaction of fusidic acid with simvastatin.
    Burtenshaw AJ; Sellors G; Downing R
    Anaesthesia; 2008 Jun; 63(6):656-8. PubMed ID: 18477279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin.
    Magee CN; Medani SA; Leavey SF; Conlon PJ; Clarkson MR
    Am J Kidney Dis; 2010 Nov; 56(5):e11-5. PubMed ID: 20888103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhabdomyolysis with atorvastatin and fusidic acid.
    O'Mahony C; Campbell VL; Al-Khayatt MS; Brull DJ
    Postgrad Med J; 2008 Jun; 84(992):325-7. PubMed ID: 18644925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe statin-induced rhabdomyolysis mimicking Guillain-Barré syndrome in four patients with diabetes mellitus treated with fusidic acid.
    Collidge TA; Razvi S; Nolan C; Whittle M; Stirling C; Russell AJ; Mann AC; Deighan CJ
    Diabet Med; 2010 Jun; 27(6):696-700. PubMed ID: 20546290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.
    McAdams M; Staffa J; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):229-39. PubMed ID: 18175291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhabdomyolysis and statins: A pharmacovigilance comparative study between statins.
    Montastruc JL
    Br J Clin Pharmacol; 2023 Aug; 89(8):2636-2638. PubMed ID: 37186323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhabdomyolysis following co-prescription of fusidic acid and atorvastatin.
    Teckchandani S; Robertson S; Almond A; Donaldson K; Isles C
    J R Coll Physicians Edinb; 2010 Mar; 40(1):33-6. PubMed ID: 21125037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin Associated Muscular Adverse Effects.
    Kammoun R; Charfi O; Lakhoua G; Zaiem A; Daghfous R; Kastalli S; Aouinti I; Aidli SE
    Curr Drug Saf; 2024; 19(1):114-116. PubMed ID: 36847228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database.
    Do C; Huyghe E; Lapeyre-Mestre M; Montastruc JL; Bagheri H
    Drug Saf; 2009; 32(7):591-7. PubMed ID: 19530745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins for primary prevention and rhabdomyolysis: A nationwide cohort study in France.
    Coste J; Billionnet C; Rudnichi A; Pouchot J; Dray-Spira R; Giral P; Zureik M
    Eur J Prev Cardiol; 2019 Mar; 26(5):512-521. PubMed ID: 29799296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A timely reminder about the concomitant use of fusidic acid with statins.
    Cowan R; Johnson PD; Urbancic K; Grayson ML
    Clin Infect Dis; 2013 Jul; 57(2):329-30. PubMed ID: 23588554
    [No Abstract]   [Full Text] [Related]  

  • 16. Statin-associated myopathy.
    Thompson PD; Clarkson P; Karas RH
    JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center Database.
    Boonmuang P; Nathisuwan S; Chaiyakunapruk N; Suwankesawong W; Pokhagul P; Teerawattanapong N; Supsongserm P
    Drug Saf; 2013 Sep; 36(9):779-87. PubMed ID: 23615756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal rhabdomyolysis following the co-prescription of fusidic acid and pravastatin.
    Bachoumas K; Fiancette M; Lascarrou JB; Lacherade JC; Leclair F; Reignier J
    Med Mal Infect; 2015 Oct; 45(10):417-9. PubMed ID: 26472060
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute rhabdomyolysis after atorvastatin and fusidic acid therapy.
    Wenisch C; Krause R; Fladerer P; El Menjawi I; Pohanka E
    Am J Med; 2000 Jul; 109(1):78. PubMed ID: 10991749
    [No Abstract]   [Full Text] [Related]  

  • 20. Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction.
    Strandell J; Bate A; Hägg S; Edwards IR
    Br J Clin Pharmacol; 2009 Sep; 68(3):427-34. PubMed ID: 19740401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.